Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
EHAB

EHAB - Enhabit Inc Stock Price, Fair Value and News

$10.34-0.04 (-0.39%)
Market Closed

66/100

EHAB

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

66/100

EHAB

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$13.83

Target 3M

$11.48

Target 6M

$12.21

EHAB Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

EHAB Price Action

Last 7 days

-3.7%

Last 30 days

9.8%

Last 90 days

26.4%

Trailing 12 Months

20.7%

EHAB RSI Chart

EHAB Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

EHAB Valuation

Market Cap

523.3M

Price/Earnings (Trailing)

-43.97

Price/Sales (Trailing)

0.5

EV/EBITDA

55.7

Price/Free Cashflow

9.05

EHAB Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$13.83

Target 3M

$11.48

Target 6M

$12.21

EHAB Fundamentals

EHAB Revenue

Revenue (TTM)

1.0B

Rev. Growth (Yr)

3.94%

Rev. Growth (Qtr)

-0.94%

EHAB Earnings

Earnings (TTM)

-11.9M

Earnings Growth (Yr)

110.07%

Earnings Growth (Qtr)

113.46%

EHAB Profitability

EBT Margin

-0.87%

Return on Equity

-2.1%

Return on Assets

-0.97%

Free Cashflow Yield

11.05%

EHAB Investor Care

Shares Dilution (1Y)

0.64%

Diluted EPS (TTM)

-0.24

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20251.0B1.0B1.0B0
20241.0B1.0B1.0B1.0B
20231.1B1.1B1.0B1.0B
20221.1B1.1B1.1B1.1B
202101.1B1.1B1.1B
20200001.1B
Get all data in R, Python etc through our Historical Stock Data APIs

About Enhabit Inc

EHAB
Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. As of December 31, 2022, it operated in 252 home health agencies and 105 hospice agencies across 23 states. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was incorporated in 2014 and is based in Dallas, Texas.
 CEO
 WEBSITEehab.com
 SECTORHealthcare
 INDUSTRYMedical Care Facilities
 EMPLOYEES10000

Enhabit Inc Frequently Asked Questions

EHAB is the stock ticker symbol of Enhabit Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Enhabit Inc is 523.28 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check EHAB's fair value in chart for subscribers.

The fair value guage provides a quick view whether EHAB is over valued or under valued. Whether Enhabit Inc is cheap or expensive depends on the assumptions which impact Enhabit Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for EHAB.

As of Wed Jan 28 2026, EHAB's PE ratio (Price to Earnings) is -43.97 and Price to Sales (PS) ratio is 0.5. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. EHAB PE ratio will change depending on the future growth rate expectations of investors.